StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30
$0.77−0.02 (-2.23%)

Close on Nov 20, 2026Market cap $99.29MP/E –Yield –

Organogenesis shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Organogenesis's shares outstanding was 129M at Jun 30, 2026. For fiscal 2025 it was 130M, down 1.1% from the year before. The highest annual figure on record is 134M in fiscal 2021.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025130M-1.1%
FY2024Dec 31, 2024132M-0.8%
FY2023Dec 31, 2023133M+0.3%
FY2022Dec 31, 2022132M-1.0%
FY2021Dec 31, 2021134M+20.0%
FY2020Dec 31, 2020111M+19.9%
FY2019Dec 31, 201993M+33.9%
FY2018Dec 31, 201869M+8.5%
FY2017Dec 31, 201764M+1.1%
FY2016Dec 31, 201663M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026129M+1.4%
Q1 FY2026Mar 31, 2026128M+1.2%
Q4 FY2025Dec 31, 2025141M+8.7%
Q3 FY2025Sep 30, 2025131M-2.3%
Q2 FY2025Jun 30, 2025127M-4.3%
Q1 FY2025Mar 31, 2025126M-4.2%
Q4 FY2024Dec 31, 2024130M-2.2%
Q3 FY2024Sep 30, 2024134M+0.4%
Q2 FY2024Jun 30, 2024133M-0.4%
Q1 FY2024Mar 31, 2024132M+0.6%
Q4 FY2023Dec 31, 2023133M+0.6%
Q3 FY2023Sep 30, 2023133M+0.9%
Q2 FY2023Jun 30, 2023133M+0.4%
Q1 FY2023Mar 31, 2023131M+1.8%
Q4 FY2022Dec 31, 2022132M-1.1%
Q3 FY2022Sep 30, 2022132M-1.2%
Q2 FY2022Jun 30, 2022133M-1.0%
Q1 FY2022Mar 31, 2022129M-3.5%
Q4 FY2021Dec 31, 2021133M+1.6%
Q3 FY2021Sep 30, 2021134M+23.4%
Q2 FY2021Jun 30, 2021134M+28.0%
Q1 FY2021Mar 31, 2021133M+27.7%
Q4 FY2020Dec 31, 2020131M+34.1%
Q3 FY2020Sep 30, 2020108M+17.6%
Q2 FY2020Jun 30, 2020105M+15.5%
Q1 FY2020Mar 31, 2020104M+15.3%
Q4 FY2019Dec 31, 201998M+27.1%
Q3 FY2019Sep 30, 201992M+32.8%
Q2 FY2019Jun 30, 201991M+36.6%
Q1 FY2019Mar 31, 201991M+40.9%
Q4 FY2018Dec 31, 201877M+20.0%
Q3 FY2018Sep 30, 201869M+8.5%
Q2 FY2018Jun 30, 201866M+3.7%
Q1 FY2018Mar 31, 201864M-3.5%
Q4 FY2017Dec 31, 201764M+598.2%
Q3 FY2017Sep 30, 201764M+753.9%
Q2 FY2017Jun 30, 201764M–
Q1 FY2017Mar 31, 201767M–
Q4 FY2016Dec 31, 20169M–
Q3 FY2016Sep 30, 20168M–

More Organogenesis figures

See a number that looks wrong?